Krystal Biotech (KRYS) Profit After Tax (2016 - 2026)
Krystal Biotech recorded quarterly Profit After Tax of $55.9 million in Q1 2026, up 8.82% quarter-over-quarter from $51.4 million in Q4 2025, and up 56.53% year-over-year from $35.7 million in Q1 2025.
Krystal Biotech's Profit After Tax history runs 11 years deep, the most recent figure standing at $55.9 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 56.53% year-over-year to $55.9 million; the TTM figure through Mar 2026 stood at $225.0 million (up 81.53% YoY), while the FY2025 annual figure was $204.8 million, up 129.74% from the prior year.
- Profit After Tax came in at $55.9 million for Q1 2026 at Krystal Biotech, up from $51.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $80.7 million in Q3 2023 to a low of -$50.0 million in Q1 2022.
- A 5-year average of $13.0 million and a median of $15.6 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 215.99% in 2022 and jumped 3734.01% in 2025, its largest moves.
- Krystal Biotech's Profit After Tax stood at -$32.1 million in 2022, then jumped by 127.12% to $8.7 million in 2023, then soared by 423.23% to $45.5 million in 2024, then grew by 13.02% to $51.4 million in 2025, then climbed by 8.82% to $55.9 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $55.9 million, $51.4 million, and $79.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 55.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.93 Mn |
| Dec 31, 2025 | 51.40 Mn |
| Sep 30, 2025 | 79.37 Mn |
| Jun 30, 2025 | 38.33 Mn |
| Mar 31, 2025 | 35.73 Mn |
| Dec 31, 2024 | 45.48 Mn |
| Sep 30, 2024 | 27.18 Mn |
| Jun 30, 2024 | 15.57 Mn |
| Mar 31, 2024 | 932,000.00 |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 80.75 Mn |
| Jun 30, 2023 | -33.21 Mn |
| Mar 31, 2023 | -45.30 Mn |
| Dec 31, 2022 | -32.05 Mn |
| Sep 30, 2022 | -29.85 Mn |
| Jun 30, 2022 | -28.11 Mn |
| Mar 31, 2022 | -49.97 Mn |
| Dec 31, 2021 | -21.81 Mn |
| Sep 30, 2021 | -15.59 Mn |
| Jun 30, 2021 | -16.36 Mn |
| Mar 31, 2021 | -15.81 Mn |
| Dec 31, 2020 | -10.38 Mn |
| Sep 30, 2020 | -9.61 Mn |
| Jun 30, 2020 | -6.83 Mn |
| Mar 31, 2020 | -5.34 Mn |
| Dec 31, 2019 | -5.36 Mn |
| Sep 30, 2019 | -4.27 Mn |
| Jun 30, 2019 | -5.35 Mn |
| Mar 31, 2019 | -4.11 Mn |
| Dec 31, 2018 | -3.71 Mn |
| Sep 30, 2018 | -2.76 Mn |
| Jun 30, 2018 | -2.28 Mn |
| Mar 31, 2018 | -2.15 Mn |
| Dec 31, 2017 | -1.39 Mn |
| Sep 30, 2017 | -5.27 Mn |
| Jun 30, 2017 | -759,000.00 |
| Mar 31, 2017 | -494,000.00 |
| Dec 31, 2016 | -627,000.00 |
| Sep 30, 2016 | -322,000.00 |